J, Kruper R, Schüle R, Pantel K, Taubert H, Duensing S, Culig Z, Aigner A, Klapper W, Jonigk D , Philipp Kühnel M , Merseburger AS, Kirfel J, Sailer V, Perner S. Manuscript Title: Analysis of tripartite [...] Jonigk D , Chocron R, Pier GB, Gendron N, Pons S, Diehl JL, Margadant C, Guerin C, Huijbers EJM, Philippe A, Chapuis N, Nowak-Sliwinska P, Karagiannidis C, Sanchez O, Kümpers P, Skurnik D, Randi AM, Griffioen [...] Jonigk D , Chocron R, Pier GB, Gendron N, Pons S, Diehl JL, Margadant C, Guerin C, Huijbers EJM, Philippe A, Chapuis N, Nowak-Sliwinska P, Karagiannidis C, Sanchez O, Kümpers P, Skurnik D, Randi AM, Griffioen

Haake K, Merkert S, Schmidt N, Mucci A, Ackermann M, Schubert M, Happle C, Kühnel MP , Blank P, Philipp F, Goethe R, Jonigk D , Martin U, Kalinke U, Baumann U, Schambach A, Roesler J, Lachmann N: Impaired

target" 16.02.2015, Special lecture (11 am, Seminar Room Cellular Chemistry, I03-04-2040, MHH) Dr. Philipp Schmalhorst, Institute of Science and Technology Austria (IST Austria), Klosterneuburg, Austria: [...] Living Cells in the Dry State: Lessons from Nature 27.03.2013 (5 p.m. c.t. , Lecture Hall H) Prof. Philipp Sasse, MD, Institute of Physiology I, University of Bonn, Life & Brain Center: “New experimental [...] cardiac fibroblasts 15.09.2010, Special lecture (6.00 pm, s.t., building J1, lecture hall N) Dr. Carl-Philipp Heisenberg, Max-Planck-Institute of Molecular Cell Biology and Genetics, Dresden: Cell and Tissue

Interdisziplinäre und translationale Onkologie In Folge der zunehmenden Komplexität onkologischer Therapiekonzepte, sowie mit der steigenden Zahl von Langzeitüberlebenden nach multimodalen Therapiekon

071902.PMID: 32674482 Free PMC article. Haake K, Neehus A-L , Buchegger T, Kühnel MP , Blank P, Philipp F, Oleaga-Quintas C, Schulz A, Grimley M, Goethe R, Jonigk D , Kalinke U, Boisson-Dupuis S, Casanova

Anti-Inflammatory Regulation in iPSC-Derived Macrophages. Hoffmann D, Sens J, Brennig S, Brand D, Philipp F, Vollmer Barbosa P, Kuehle J, Steinemann D, Lenz D, Buchegger T, Morgan M, Falk CS , Klein C, Lachmann

the development of innovative therapies for challenging diseases. September 2024 Elisa Mohr and Philipp Höhne receive Poster Awards The Fraunhofer CIMD Symposium "RNA-Based Therapeutics" took place on [...] from academia and industry in the field of RNA-based therapeutics. IMTTS scientists Elisa Mohr and Philipp Höhne received the Poster Award for their excellent poster presentations. Elisa Mohr presented " [...] in 3D: Human organoids as a multipurpose tool to recapitulate cardiac pathophysiology in vitro". Philipp Höhne gave a presentation on "Superparamagnetic nanoparticles as cardiac-targeted delivery tools

Arch Pharmacol. 2024 Aug 23. doi: 10.1007/s00210-024-03377-0. Epub ahead of print. PMID: 39177786. Philipp M, Seifert R. Legal and scientific deficiencies of drug advertisements on German television. Naunyn

Vauth "MK3 as a disease causing kinase" Gebäude I3, Ebene 01, R.-Nr. 2020, 12.00 Uhr 19.05.2017 Philipp Trulley "Alternative translation of MK2 Same same - but different - but still same?" Gebäude I3,

related macular degeneration mouse models Elisabeth Richert, Claus von der Burchard, Alexa Klettner, Philipp Arnold, Ralph Lucius, Ralf Brinkmann, Johann Roider, Jan Tode Cytokine: X 2 (2020) 100031; https://doi